Purpose
To evaluate an mRNA-based HIV vaccine designed to improve health outcomes for people living with and without HIV, particularly in low- and middle-income countries
Grantee
Division
Global Health
Date
JANUARY 2026
Region served
GLOBAL
Committed amount
$24,925,805
Grant topic
Create Novel Technology Platform Capabilities,
HIV
Duration (months)
41
Grantee location
Mainz, Germany
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.